Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
02/2002
02/28/2002WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
02/28/2002WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/28/2002WO2002015891A2 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
02/28/2002WO2001070720A3 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
02/28/2002US20020026059 Use as microbicides in crop protection
02/28/2002US20020026055 Aminopyridine-containing thiourea inhibitors of herpes viruses
02/28/2002US20020025977 Psychological disorders; nervous system disorders
02/28/2002US20020025965 Antiserotonine agents
02/28/2002DE10040481A1 Combination of phenylene-1,4-bis-(2-benzimidazyl)-3,3',5,5'-tetrasulfonic acid or salt and 2,2'-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)-phenol) is used in cosmetic or dermatological formulation
02/28/2002CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/28/2002CA2415856A1 Late transition metal complexes, their use as catalysts and polymers therefrom
02/28/2002CA2415788A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
02/28/2002CA2411924A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting proteinkinases
02/27/2002EP1181280A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
02/27/2002EP1181269A1 Cell proliferation inhibitors
02/27/2002CN1337395A Novel acardite compound, its preparation method and medicinal composition containing said compound
02/26/2002US6350770 Microbiocides, insecticides
02/26/2002CA2284470C New crystalline form of omeprazole
02/26/2002CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them
02/21/2002WO2002014294A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
02/21/2002WO2002014275A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function
02/21/2002WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/21/2002US20020022728 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests
02/21/2002US20020022625 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments
02/21/2002US20020022624 Azaindole derivatives and their use as therapeutic agents
02/21/2002US20020022622 Administering effective amount of oxalzole, thiazole or imidazole derivatives to cure diseases associated with protein aging
02/20/2002EP1180519A1 Hydrochloride of fused-heterocycle compound
02/20/2002CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
02/20/2002CN1336920A Telmisartan polymorphs, methods for producing same and their use in prepn. of a medicament
02/19/2002USRE37556 Superoxide radical inhibitor
02/19/2002US6348487 2-phenyl benzimidazole derivatives as MCP-1 antagonists
02/19/2002US6348482 Catechols as antimicrobial agents
02/19/2002US6348032 Method of inhibiting neoplastic cells with benzimidazole derivatives
02/14/2002WO2002012224A2 Bicyclic compounds as h3 receptor ligands
02/14/2002WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/14/2002WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/14/2002US20020019401 Psychological disorders; adjustment of dopamine concentration
02/14/2002CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/14/2002CA2419027A1 Bicyclic compounds as h3 receptor ligands
02/14/2002CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
02/13/2002EP1178989A1 Process for making fused-ring imidazo-containing compounds
02/13/2002EP1178977A1 Ion channel modulating agents
02/12/2002US6346624 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
02/12/2002US6346532 Antidiabetic, antilipemic, and hypoglycemic agents; adrenergic stimulants
02/12/2002CA2110273C Benzimidazole derivatives, their preparation process and their use in the fields of therapeutics and cosmetics
02/12/2002CA2088742C Benzimidazole and imidazopyridine derivatives and their application
02/07/2002WO2000032578A8 Benzimidazole compounds that are vitronectin receptor antagonists
02/07/2002US20020016461 Biphenyl and biphenyl-analogous compounds as integrin antagonists
02/07/2002US20020016460 Pyridine -imidazole, -thiazole or -oxazole derivatives; treating autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer
02/07/2002US20020016349 2-phenyl-benzimidazolesulfonic acid derivatives, sunscreen agents, cosmetics
02/07/2002US20020016347 Benzophenones as inhibitors of IL-1beta and TNF-alpha
02/06/2002EP1178039A1 Derivatives of phenyl(thio)urea and phenyl(thio)carbamate fungicides
02/06/2002EP1178010A1 Colorless aqueous ammonium sulfide solution
02/06/2002EP1177792A2 Dopamine D4 Ligands for the treatment of novelty-seeking disorders
02/06/2002EP1177197A2 Polyamines and their use in therapy
02/06/2002EP1177181A1 Substituted bicyclic compounds
02/06/2002EP1177178A1 Heterocyclically substituted benzimidazoles, the production and application thereof
02/06/2002EP1176958A1 Novel catechols as antimicrobial agents
02/06/2002CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists
02/06/2002CN1334798A Phenylglycine derivatives
02/05/2002US6344564 Fungicidal 2-imidazolin-5-ones and 2-imidazoline-5-thiones
02/05/2002US6344563 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
01/2002
01/31/2002WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
01/31/2002WO2001070682A3 Carbocyclic side chain containing metalloprotease inhibitors
01/31/2002WO2001021160A3 Carboxymide and aniline derivatives as selective inhibitors of pathogens
01/31/2002US20020013474 Process for the preparation of UV filter substances
01/31/2002DE10035011A1 Pure N,N'-carbonyl-diazole preparation in high yield, by reacting azolide salt with phosgene in aromatic or ether solvent
01/30/2002EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
01/30/2002CN1333755A Benzimidazole compounds that are vitronectin receptor antagonists
01/30/2002CN1333754A Benzoheterocycles and their use as MEK inhibitors
01/29/2002US6342633 O-benzyl oxime ether derivatives and their use as pesticides
01/29/2002US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
01/24/2002US20020010343 Compounds having IgE affecting properties
01/24/2002US20020010286 Multifunctional cyanate ester and epoxy blends
01/24/2002US20020007522 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected
01/24/2002US20020007521 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected
01/24/2002DE19963234A1 New N,N-disubstituted piperazine and diazacycloheptane derivatives useful in treatment of hyperlipidemia, atherosclerosis, diabetes mellitus, adiposity and pancreatitis
01/23/2002EP1173423A1 Benzimidazolones and analogues and their use as progesterone receptor ligands
01/23/2002EP1173422A1 Bis-benzazoles and their use as antineoplastic agents
01/23/2002EP1173407A1 Method for nitrating aniline derivatives
01/23/2002EP1173223A2 Conjugates as therapies for cancers and prostate diseases
01/23/2002EP1173169A1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
01/23/2002CN1332731A Substituted benzimidazoles and their prep. and use
01/22/2002US6340685 Antiinflammatory agents
01/17/2002WO2002004426A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
01/17/2002WO2002004425A2 Viral polymerase inhibitors
01/17/2002US20020007071 Treating disorders which include neuropeptide Y excess; antagonists, antagonism
01/17/2002US20020007069 Reacting 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl) methyl)thio)benzimidazole with 3-chloroperoxybenzoic acid in ethyl acetate; purifying by dissolving in methylamine and by precipitation via addition of hydrochloric acid; purity
01/17/2002US20020007045 For inhibiting the aggregation of blood platelets; 3-(4-Aminomethyl-phenyl)-1-(2-(3,4-dichloro-phenyl)-2-hydroxy-ethyl)-1 -isopropyl-urea for example
01/17/2002US20020006948 Central nervous system disorders; antiinflammatory agents
01/17/2002US20020006922 Metalloprotease inhibitors
01/17/2002DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments
01/17/2002DE10032587A1 4-Alkoxy-cyclohexan-1-amino-carbonsäureester und Verfahren zu ihrer Herstellung 4-alkoxy-1-amino-cyclohexane-carboxylic acid esters and procedures for their preparation
01/16/2002EP1172443A1 Method for screening cysteine protease inhibitor
01/16/2002EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors
01/16/2002EP1171424A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
01/16/2002CN1331683A 2-phenylbenzimidazoles and 2-phenylindoles, and prodn. and use thereof
01/16/2002CN1331682A Substituted 2-phenylbenzimidazoles, prodn. thereof and their use
01/16/2002CN1331674A Sulfonamide hydroxamates
01/16/2002CN1077878C Prepn. of bicyclohexane derivative